Respironics recall of 52 ventilators close to completion
Philips Healthcare-owned Respironics has completed notifying customers of a voluntary recall of 52 Trilogy 100 ventilators sold in the U.S.
The company said, in a Jan. 12 news release, that all but one of the affected devices have already been removed from use, and all affected customers have acknowledged receipt of the notice.
The Murrysville, Pa.-based company said it has received no reports on malfunctions or failures, but decided to initiate the recall last fall after concluding from an internal review that the model’s blower was at risk of failure.
Respironics notified the FDA of its decision to pull back the affected product on Oct. 7, 2011. Other models in the product line, the Trilogy 200 and 202, were not affected by the recall.
The company said, in a Jan. 12 news release, that all but one of the affected devices have already been removed from use, and all affected customers have acknowledged receipt of the notice.
The Murrysville, Pa.-based company said it has received no reports on malfunctions or failures, but decided to initiate the recall last fall after concluding from an internal review that the model’s blower was at risk of failure.
Respironics notified the FDA of its decision to pull back the affected product on Oct. 7, 2011. Other models in the product line, the Trilogy 200 and 202, were not affected by the recall.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.